Group A (n = 7) | Group B (n = 11) | p Value | |
---|---|---|---|
Clinical findings | |||
Age (years) | 49 (13) | 55 (15) | NS |
Range | (23 to 60) | (23 to 70) | |
Male/female | 5/2 | 10/1 | |
NYHA class (II/III) | 6/1 | 8/3 | NS |
β Blocker use | 4 | 3 | NS |
Alcohol intake (> 100 g/day) | 3 | 4 | NS |
Echocardiographic findings | |||
LVEDD (mm) | 59 (9) | 65 (7) | NS |
LVESD (mm) | 52 (9) | 56 (8) | NS |
Haemodynamic findings | |||
LVEF (%) | 35 (8) | 33 (9) | NS |
LVEDVI (ml/m2) | 154 (48) | 157 (49) | NS |
LVESVI (ml/m2) | 95 (30) | 105 (40) | NS |
LVEDP (mm Hg) | 9 (3) | 16 (10) | NS |
PCW (mm Hg) | 8 (2) | 12 (9) | NS |
PA mean (mm Hg) | 20 (5) | 22 (9) | NS |
RVEDP (mm Hg) | 7 (2) | 9 (5) | NS |
RA mean (mm Hg) | 5 (2) | 6 (4) | NS |
Cardiac index (l/min/m2) | 2.7 (0.7) | 2.2 (0.5) | NS |
Values are n or mean (SD).
LVEDD, left ventricular end diastolic dimension; LVEDVI, left ventricular end diastolic volume index; LVEF, left ventricular ejection fraction; LVEDP, left ventricular end diastolic pressure; LVESD, left ventricular end systolic dimension; LVESVI, left ventricular end systolic volume index; NYHA, New York Heart Association; PA, pulmonary artery; PCW, pulmonary capillary wedge pressure; RA, right atrium; RVEDP, right ventricular end diastolic pressure.